Literature DB >> 19287130

Effect of severe aortic stenosis on the outcome in elderly patients undergoing repair of hip fracture.

David Leibowitz1, Gurion Rivkin, Jochanan Schiffman, David Rott, A Teddy Weiss, Yoav Mattan, Leonid Kandel.   

Abstract

BACKGROUND: The perioperative assessment and management of elderly patients with hip fracture and significant aortic stenosis (AS) is an increasingly common clinical problem with little data available to guide perioperative management.
OBJECTIVES: It was the aim of this study to examine the incidence of perioperative events in an elderly population of patients with severe AS undergoing repair of hip fracture as compared with controls without severe AS.
METHODS: Patients over the age of 70 with an echocardiographic diagnosis of severe AS defined as an aortic valve area <or=1.0 cm(2) who underwent surgery for hip fracture repair were retrospectively identified. An age-matched group of patients without a history of AS who underwent surgical repair of hip fracture was the control group. The primary outcome of the incidence of postoperative cardiac events defined as death, acute coronary syndrome or pulmonary edema within 30 days was compared.
RESULTS: Thirty-two patients with AS (median age 84.5 years, range 72-94; 27 females and 5 males) and 88 controls (median age 86 years, range 80-95; 67 females and 21 males) were entered into the study. There were no significant differences between the AS group and controls for 30-day mortality (6.2 vs. 6.8%) or for the total cardiac event rate (18.7 vs. 11.8%).
CONCLUSIONS: Our results demonstrate that elderly patients with severe AS can safely undergo repair of hip fractures with a mortality and morbidity comparable with a control population. These patients should not be denied surgery on the basis of their aortic valve disease. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19287130     DOI: 10.1159/000209245

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  7 in total

Review 1.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

2.  Do the potential benefits of metal-on-metal hip resurfacing justify the increased cost and risk of complications?

Authors:  Kevin J Bozic; Christine M Pui; Matthew J Ludeman; Thomas P Vail; Marc D Silverstein
Journal:  Clin Orthop Relat Res       Date:  2010-09       Impact factor: 4.176

3.  Cardiac overscreening hip fracture patients.

Authors:  S J M Smeets; B P W van Wunnik; M Poeze; G D Slooter; J P A M Verbruggen
Journal:  Arch Orthop Trauma Surg       Date:  2019-08-31       Impact factor: 3.067

4.  Severe aortic stenosis is associated with perioperative mortality in proximal femur fracture patients.

Authors:  Patrick K Cronin; Jeffrey J Olson; Mitchel B Harris; Michael J Weaver
Journal:  OTA Int       Date:  2020-05-05

5.  Adverse outcomes after noncardiac surgery in patients with aortic stenosis.

Authors:  Ying-Hsuan Tai; Chuen-Chau Chang; Chun-Chieh Yeh; Yih-Giun Cherng; Ta-Liang Chen; Chien-Chang Liao
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

6.  Hip Fracture Surgery in Severe Aortic Stenosis: A Study of Factors Affecting Mortality.

Authors:  Carlo Rostagno; Alessandro Cartei; Gaia Rubbieri; Alice Ceccofiglio; Roberto Civinini; Massimo Curcio; Gianluca Polidori; Alberto Boccaccini
Journal:  Clin Interv Aging       Date:  2022-08-04       Impact factor: 3.829

7.  Prediction of Early Postoperative Major Cardiac Events and In-Hospital Mortality in Elderly Hip Fracture Patients: The Role of Different Types of Preoperative Cardiac Abnormalities on Echocardiography Report.

Authors:  Xuepan Chen; Yuanchen Ma; Zhantao Deng; Qingtian Li; JunXing Liao; Qiujian Zheng
Journal:  Clin Interv Aging       Date:  2020-05-27       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.